BTG PLC (BTG.L)

BTG.L on London Stock Exchange

577.50GBp
12 Feb 2016
Change (% chg)

13.00p (+2.30%)
Prev Close
564.50p
Open
569.50p
Day's High
577.50p
Day's Low
562.00p
Volume
2,991,122
Avg. Vol
743,451
52-wk High
809.50p
52-wk Low
504.00p

BTG.L

Chart for BTG.L

About

BTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company's Interventional Medicine segment offers a portfolio of... (more)

Overall

Beta: 0.41
Market Cap(Mil.): £2,211.64
Shares Outstanding(Mil.): 382.97
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 49.28 30.46 37.46
EPS (TTM): 0.12 -- --
ROI: 5.65 14.83 14.17
ROE: 6.59 15.40 14.92
Search Stocks

BTG boss scans for next deals as lung device bet pays off

LONDON After being vindicated in her 2014 purchase of a U.S. company with a device to prop open diseased lungs, the chief executive of British healthcare group BTG is scouring the horizon for the next promising acquisition.

17 Dec 2015

BTG gets triple dose of good news on new products

LONDON Specialist medicine company BTG received a triple dose of good news on Monday as U.S. regulators approved two new treatments and a clinical trial of a novel lung device produced positive results.

14 Dec 2015

BRIEF-BTG H1 revenue climbs 20 pct

* Operating profit before acquisition adjustments and reorganisation costs was £62.9m (h1 14/15: £56.8m)

10 Nov 2015

Earnings vs. Estimates

Search Stocks